Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:32:44 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Q:BIOC - BIOCEPT INC - http://biocept.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BIOC - QDEFUNCT0.4349    27.027  0.32Oct 24Sep 2115 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2023-09-21 08:00U:BIOCNews ReleaseEnrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept ¢ € ™s CNSide ¢ „ ¢ Assay to Evaluate Patients with Leptomeningeal Metastases
2023-09-08 08:00U:BIOCNews ReleaseBiocept Signs CNSide ¢ „ ¢ Licensing Agreement with Plus Therapeutics
2023-09-05 08:00U:BIOCNews ReleaseBiocept to Participate in the H.C. Wainwright Global Investment Conference
2023-08-25 08:00U:BIOCNews ReleaseBiocept to Hold Business Update Conference Call on August 30, 2023
2023-08-14 16:05U:BIOCNews ReleaseBiocept Reports Second Quarter 2023 Financial Results
2023-08-14 08:00U:BIOCNews ReleaseBiocept ¢ € ™s CNSide ¢ „ ¢ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
2023-07-13 18:15U:BIOCNews ReleaseBiocept Announces the Passing of Board Chair M. Faye Wilson
2023-06-20 16:15U:BIOCNews ReleaseBiocept Names Antonino Morales as President and Chief Executive Officer
2023-06-14 16:05U:BIOCNews ReleaseBiocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
2023-06-05 08:00U:BIOCNews ReleaseScientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept ¢ € ™s CNSide ¢ „ ¢ Versus Cytology
2023-05-24 20:39U:BIOCNews ReleaseBiocept Announces Pricing of $5.0 Million Underwritten Public Offering
2023-05-17 08:00U:BIOCNews ReleaseBiocept Announces One-for-Thirty Reverse Stock Split
2023-05-10 16:05U:BIOCNews ReleaseBiocept Reports First Quarter 2023 Financial Results